Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Cancer Med ; 3(1): 47-60, 2014 Feb.
Article in English | MEDLINE | ID: mdl-24403176

ABSTRACT

Angiogenesis plays a major role in tumor growth and metastasis, with tumor perfusion regarded as a marker for angiogenesis. To evaluate antiangiogenic treatment response in vivo, we investigated arterial spin labeling (ASL) magnetic resonance imaging (MRI) to measure tumor perfusion quantitatively. Chronic and 24-h acute treatment responses to bevacizumab were assessed by ASL and dynamic-contrast-enhanced (DCE) MRI in the A498 xenograft mouse model. After the MRI, tumor vasculature was assessed by CD34 staining. After 39 days of chronic treatment, tumor perfusion decreased to 44.8 ± 16.1 mL/100 g/min (P < 0.05), compared to 92.6 ± 42.9 mL/100 g/min in the control group. In the acute treatment study, tumor perfusion in the treated group decreased from 107.2 ± 32.7 to 73.7 ± 27.8 mL/100 g/min (P < 0.01; two-way analysis of variance), as well as compared with control group post dosing. A significant reduction in vessel density and vessel size was observed after the chronic treatment, while only vessel size was reduced 24 h after acute treatment. The tumor perfusion correlated with vessel size (r = 0.66; P < 0.005) after chronic, but not after acute treatment. The results from DCE-MRI also detected a significant change between treated and control groups in both chronic and acute treatment studies, but not between 0 and 24 h in the acute treatment group. These results indicate that tumor perfusion measured by MRI can detect early vascular responses to antiangiogenic treatment. With its noninvasive and quantitative nature, ASL MRI would be valuable for longitudinal assessment of tumor perfusion and in translation from animal models to human.


Subject(s)
Angiogenesis Inhibitors/administration & dosage , Kidney Neoplasms/drug therapy , Neovascularization, Pathologic/drug therapy , Animals , Antibodies, Monoclonal, Humanized/administration & dosage , Bevacizumab , Humans , Kidney Neoplasms/pathology , Magnetic Resonance Angiography , Mice , Neovascularization, Pathologic/genetics , Neovascularization, Pathologic/pathology , Regional Blood Flow , Spin Labels , Xenograft Model Antitumor Assays
2.
Pflugers Arch ; 462(4): 587-97, 2011 Oct.
Article in English | MEDLINE | ID: mdl-21796340

ABSTRACT

This article presents a novel model of acupuncture physiology based on cellular calcium activation by an acoustic shear wave (ASW) generated by the mechanical movement of the needle. An acupuncture needle was driven by a piezoelectric transducer at 100 Hz or below, and the ASW in human calf was imaged by magnetic resonance elastography. At the cell level, the ASW activated intracellular Ca(2+) transients and oscillations in fibroblasts and endothelial, ventricular myocytes and neuronal PC-12 cells along with frequency-amplitude tuning and memory capabilities. Monitoring in vivo mammalian experiments with ASW, enhancement of endorphin in blood plasma and blocking by Gd(3+) were observed; and increased Ca(2+) fluorescence in mouse hind leg muscle was imaged by two-photon microscopy. In contrast with traditional acupuncture models, the signal source is derived from the total acoustic energy. ASW signaling makes use of the anisotropy of elasticity of tissues as its waveguides for transmission and that cell activation is not based on the nervous system.


Subject(s)
Acoustic Stimulation , Acupuncture Therapy , Calcium Signaling/physiology , Muscle, Skeletal/physiology , Adult , Animals , Anisotropy , Elasticity Imaging Techniques , Humans , Male , Mice , Models, Theoretical , NIH 3T3 Cells , PC12 Cells , Rats , Thigh
SELECTION OF CITATIONS
SEARCH DETAIL
...